A 2-year study 8 1-year weight loss followed by 1-year prevention of weight regain9 TO ASSESS THE SAFETY, TOLERABILITY AND EFFICACY OF l-000899055 in obese patients

• Conditions: obesity; MedDRA version: 6.1Level: PTClassification code 10029883

• Registration Number: EUCTR2005-002454-21-IT
• Lead Sponsor: MERCK SHARP DOHME

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-09-12
• Last Update Posted: 24 April 2012

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 2400

Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified